Search for: "Patent Docs"
Results 561 - 580
of 1,637
Sorted by Relevance
|
Sort by Date
3 Jun 2009, 9:56 pm
§ 120 (see Patent Docs report). [read post]
17 Aug 2009, 9:59 pm
Patent Docs initially reported on this study back in February, before BIO and Thomson Reuters made the report available (see "NVCA Study Shows Decline in 2008 Investment; BIO Study Predicts Biotech Rebound in 2009"). [read post]
4 Jan 2010, 9:59 pm
By Donald Zuhn -- On New Year's Eve, we kicked off our third annual list of top biotech/pharma stories by counting down the first three of the top ten stories covered on Patent Docs in 2009 (see "Top Stories of 2009: #10, #9, and #8"). [read post]
17 Jun 2011, 9:08 pm
Patent Docs author Dr. [read post]
2 Mar 2012, 8:28 pm
Patent Docs authors and MBHB attorneys Dr. [read post]
1 Nov 2009, 9:36 pm
By Donald Zuhn -- Over the past twelve months, Patent Docs has reported on a number of papers, letters, and statements that outline positions taken by various players in the follow-on biologics (FOB) data exclusivity debate. [read post]
3 Jun 2009, 9:50 pm
In that decision, issued on April 3, the Federal Circuit reversed the District Court's denial of Lilly's motion for JMOL in view of a jury verdict of infringement and validity of the asserted claims, and affirmed the District Court's ruling that Lilly failed to establish the affirmative defense of inequitable conduct (see Patent Docs report). [read post]
22 May 2009, 6:58 pm
By Donald Zuhn -- On Wednesday, we posted a report on a BIO Super Session entitled "A Model Patent Office for the Future -- Promoting and Protecting Investments in Innovation" (see "Docs at BIO: Panel Offers Suggestions for Fixing the USPTO"). [read post]
29 Oct 2009, 9:59 pm
By Donald Zuhn -- Over the past twelve months, Patent Docs has reported on a number of papers, letters, and statements that outline positions taken by various players in the follow-on biologics data exclusivity debate. [read post]
14 Jun 2007, 4:45 am
" Blogs have been actively covering the letter and its implications: Patent Docs Promote the Progress FileWrapper Patent Prospector Patent Baristas Phosita Promote the Progress FileWrapper Patent Prospector Patent Baristas Phosita [read post]
4 Jun 2009, 9:58 pm
Doll (see Patent Docs report). [read post]
8 Jul 2014, 8:11 am
(See Doc. 2–1 at 6–7). [read post]
19 Apr 2012, 10:00 pm
The post points out two major caveats in the decision. 4) Patent Docs: Marine Polymer Technologies, Inc. v. [read post]
19 Apr 2012, 10:00 pm
The post points out two major caveats in the decision. 4) Patent Docs: Marine Polymer Technologies, Inc. v. [read post]
11 Aug 2009, 7:18 am
Patent Docs 8. 271 Patent Blog 9. [read post]
7 Apr 2009, 1:31 pm
By contrast, Patent Docs, pushing their particular subjective and outdated view of biotechnology patents, still doesn't get it, assigning multiple errors to the Federal Circuit court rather than trying to formulate a workable understanding of the rule now applied in In re Kubin and applicable to the grant or denial of all biotechnology patents in the future. [read post]
26 Jan 2012, 9:00 pm
" This post discusses Class 705, which is the generic class for innovations relating to business methods. 3) Patent Docs: The Medicines Company to Get Patent Term Extension - This post provides a breakdown of the settlement of litigation reached between the Medicines Company and APP Pharmaceuticals, and gives a detailed case background and procedural history explaining how the parties reached their final settlement. 4) The Tech Transfer Blog: New Pact Brings… [read post]
26 Jan 2012, 9:00 pm
" This post discusses Class 705, which is the generic class for innovations relating to business methods. 3) Patent Docs: The Medicines Company to Get Patent Term Extension - This post provides a breakdown of the settlement of litigation reached between the Medicines Company and APP Pharmaceuticals, and gives a detailed case background and procedural history explaining how the parties reached their final settlement. 4) The Tech Transfer Blog: New Pact Brings… [read post]
2 Jul 2014, 4:20 pm
In a speech at varying times passionate and wistful, the Judge (who is widely viewed as a strong proponent of patent law and thus appreciated by many in the biotechnology community) spoke at length about the Court and his involvement in it, and its unique place in this country and the world regarding its signal influence on U.S.... [read post]
27 Jun 2008, 4:51 am
Teleflex Inc. on biopharma patent prosecution and litigation. [read post]
